Professional Documents
Culture Documents
A Prospective 10 Year Follow Up Study of Patients With Neurofibromatosis Type 1
A Prospective 10 Year Follow Up Study of Patients With Neurofibromatosis Type 1
A Prospective 10 Year Follow Up Study of Patients With Neurofibromatosis Type 1
ORIGINAL ARTICLES
Arch Dis Child: first published as 10.1136/adc.78.5.408 on 1 May 1998. Downloaded from http://adc.bmj.com/ on March 17, 2021 by guest. Protected by copyright.
A prospective 10 year follow up study of patients
with neurofibromatosis type 1
M H Cnossen, A de Goede-Bolder, K M van den Broek, C M E Waasdorp, A P Oranje,
H Stroink, H J Simonsz, A M W van den Ouweland, D J J Halley, M F Niermeijer
were variable and often included late onset of Table 1 NIH diagnostic criteria in neurofibramatosis type
speech as well as articulatory problems. Coun- 1 (NF1). Two or more of the criteria are necessary for a
diagnosis of NF1
selling by a speech therapist was recorded.
Arch Dis Child: first published as 10.1136/adc.78.5.408 on 1 May 1998. Downloaded from http://adc.bmj.com/ on March 17, 2021 by guest. Protected by copyright.
Motor problems were defined as clumsiness on Clinical signs
evaluation by a paediatric neurologist; support Six or more café au lait spots over 5 mm in greatest diameter
by a physiotherapist was reported. Behavioural in prepubertal individuals and over 15 mm in greatest
diameter in postpubertal individuals
problems varied from attention deficit hyperac-
Two or more neurofibromas of any type or one or more
tivity disorders to aggressive behaviour and plexiform neurofibroma
depression requiring psychiatric help. Freckling in the axillary or inguinal region
Optic pathway gliomas reported in this study Optic or chiasma glioma
were detected on CT/MRI scans of the brain. Two or more Lisch nodules (iris hamartomas)
Plexiform neurofibromas were defined as A distinctive osseous lesion, such as sphenoid dysplasia or
either a large, soft swelling with ill defined thinning of long bone cortex, with or without bowing and
borders (diVuse plexiform neurofibroma) or a pseudoarthrosis
firm, spherical or ovoid shaped swelling (nodu- Family history
A first degree relative (parent, sibling, or oVspring) with NF1
lar plexiform neurofibroma).4 Plexiform neuro- by the above criteria
fibromas were interpreted as complications on
the basis of either localisation or symptomatol-
ogy. Threatening localisations included the ANALYSIS
head and neck, the vertebral column, para- Clinical data were obtained from medical
vertebrally and/or the perineum. Plexiform records and registered on a standardised form.
neurofibromas causing severe symptoms (pain, Data were analysed with Dbase IV and SPSS
functional disorders, neurological deficits, and 6.0. Associations between specific symptoms
cosmetic disfigurement) were also considered and the presence of complications were as-
to be complications. sessed by univariate analysis with the ÷2 test
Severe scoliosis was defined as a vertebral (p = 0.05, two sided). Risk factors tested
column abnormality requiring treatment, such included sex; age at NIH diagnosis; physical
as surgery or corset. characteristics observed in children with NF1,
such as macrocephaly, short stature, hyperte-
lorism, thorax abnormalities, and mild scoli-
PREVALENCE RATES osis; as well as a variety of symptoms such as
Prevalence was calculated on the basis of a learning diYculties, motor disorders, behav-
symptom or complication on 1 January 1996 in ioural problems and speech disorders.
children (younger than 18 years of age)
diagnosed with NF1 according to NIH criteria. Results
Nine children examined before 1985 by all During this prospective follow up study, 209
specialists on a regular basis were also included children were examined for a suspected
in this study. This population will be referred to diagnosis of NF1. NF1 was diagnosed accord-
as group A (n = 150). ing to NIH criteria (table 1) in 150 children
The prevalence of symptoms and complica- (64 girls, 86 boys). Five children (3.3%) died of
tions at initial presentation can be calculated malignancies during the follow up period.
easily by subtracting the number of occurring Almost half of the NF1 aVected children
symptoms/complications (n) from the overall (46%) were referred by either a general practi-
prevalence rate. tioner or other primary health care worker. The
others were referred by medical specialists.
INCIDENCE RATES
Incidence rates of symptoms and complica- PREVALENCE RATES
tions were established on 1 January 1996 in Prevalence rates of diagnostic criteria and
children (younger than 18 years of age) without complications in group A are depicted in table
complications at presentation who were diag- 2. Mean (SD) age at last examination date was
nosed with NF1. This group of children, which 10.4 (5.1) years. Mean (SD) duration of follow
is a subset of group A, will be called group B up was 4.9 (3.8) years.
(n = 95). These patients presented solely with
café au lait spots, freckling, Lisch nodules, Diagnostic criteria
and/or dermal neurofibromas. Person-years, Six or more café au lait spots of the required
the denominator of the incidence rate, was de- diameter were found in 96.7% of NF1 affected
fined by the first examination date with NF1 children (mean age at presentation of sign, 3.1
diagnosis and last examination date. Children (3.1) years). Freckling was found in 85.3%
reaching the age of 18 years before January (mean age at presentation of sign, 6.3 (4.2)
1996 were considered withdrawn alive. years). Dermal neurofibromas were found in
Incidence rates of newly presenting compli- 40.0% (mean age at presentation of sign, 8.9
cations were also computed in children with (4.5) years). Plexiform neurofibromas were
one or two complications at presentation. This found in 26.6%, Lisch nodules were found in
group will be referred to as group C (n = 55) 52.0% (mean age at presentation of sign, 8.8
and is also a subset of group A. Person-years (3.6) years), and a distinctive osseous lesion
were defined by first examination with NF1 (sphenoid dysplasia, thinning of long bone cor-
diagnosis and complication(s) and last examin- tex) was seen in 7.8% of NF1 affected children
ation date. Complications were defined as new (table 2). In addition, scalloping of the
when occurring more than one year after the vertebral bodies was seen in five (4.0%)
presenting complication(s). children and widened foramina of the vertebral
410 Cnossen, de Goede-Bolder, van den Broek, Waasdorp, Oranje, Stroink, et al
Table 2 Prevalence rates of diagnostic criteria, symptoms, and complications in 150 Table 3 Incidence rates of complications in 95 children
unselected neurofibromatosis type 1 (NF1) children (group A) presenting without complications (group B)
Arch Dis Child: first published as 10.1136/adc.78.5.408 on 1 May 1998. Downloaded from http://adc.bmj.com/ on March 17, 2021 by guest. Protected by copyright.
Huson and Obringer and Incidence rates/
% (n) colleagues7¶ (%) colleagues6 (%) 100 person-years (n)
given by Obringer and colleagues.6 However, patients, there are no comparative data avail-
descriptions of complications were not included. able. Although most of those with plexiform
neurofibromas (88.9%) and optic pathway
Arch Dis Child: first published as 10.1136/adc.78.5.408 on 1 May 1998. Downloaded from http://adc.bmj.com/ on March 17, 2021 by guest. Protected by copyright.
PREVALENCE RATES OF SYMPTOMS AND gliomas (70.6%) presented with symptoms at
COMPLICATIONS initial examination, they might also develop
Strikingly, in the study population as a whole, symptoms later on and present during follow
complications were observed in 42%; more- up. Accordingly, optic pathway gliomas have
over, one third of these children had two or been reported to develop in patients without
more complications of the disease. abnormalities on MRI scan at presentation.12
The prevalence of the diagnostic criteria and However, most endocrinological disorders
severe scoliosis were similar to those reported (57.1%) presented during follow up (table 4).
in other studies.2 6 7 Therefore, deviations from the growth velocity
Prevalence rates of learning diYculties, motor curve and premature manifestations of puberty
disorders, behavioural problems, and speech should be recognised as possible endocrine
disorders were similar to those reported in other complications of NF1. Malignancies were all
studies.8 9 The high percentages of these prob- acquired during follow up. Half of the present-
lems emphasises the necessity of following up ing tumours developed in pre-existing plexi-
NF1 aVected children and informing their form neurofibromas.
parents about the association of these symptoms An association was found between behav-
with the disease, so that educational and ioural problems and the development of
supportive measures can be taken. complications. However, behavioural problems
The prevalence of optic pathway glioma has may also be a consequence of complications in
been variously reported, depending on the children and as such cannot be considered a
indication for brain imaging: 19%, if carried risk factor.
out routinely10; 11.3%, if performed because of
suspected central nervous system tumours, eye FUTURE PROSPECTS AND RECOMMENDATIONS
problems and/or endocrinological abnormali- Our data indicate that routine x rays of the cra-
ties (this study); 5.1%, if carried out because of nium and the entire spine are unnecessary,
suspected eye problems.7 We agree that routine unless symptoms indicate these investigations.
neuroimaging for optic pathway glioma is not The observation of one case of atlantoaxial dis-
indicated because only half of the detected location in a patient with cervical dysplasias
optic pathway gliomas in our study were symp- and the 11.8% prevalence of this condition in
tomatic; one third of these presented with pro- NF1 leads to our recommending complete
gressive visual loss. One of the three children in bidirectional cervical vertebral column x rays in
this series had central precocious puberty and all NF1 patients undergoing anaesthesia and/or
an optic pathway glioma was found on MRI surgery. Visual evoked potentials were a
examination. This is in contrast with earlier valuable addition to the ophthalmological
observations of concurrence of chiasma glioma examination at first presentation. Although the
in all NF1 patients with central precocious specificity of this test is low, sensitivity is high,13
puberty.11 leading to detection and treatment of progress-
Distinct from Huson and colleagues,7 none ive optic pathway glioma at an early stage.
of the NF1 patients in this series had a Our data provide justification for follow up
rhabdomyosarcoma. Therefore, our data sug- of NF1 patients because they give the preva-
gest that this is a rare complication. Prevalence lence of complications at presentation, the
of epilepsy, pseudoarthrosis, and aqueduct ste- increase of complications (incidence rate), and
nosis were higher in the Welsh study. Contrast- the overall prevalence of specific complica-
ingly, except for two patients with delayed tions. We conclude that NF1 is a disease that is
puberty, Huson did not observe any children associated with various psychomotor problems
with endocrinological disorders.7 and severe complications during childhood.
The children merit regular surveillance by an
INCIDENCE RATES OF SYMPTOMS AND experienced paediatrician, paediatric neurolo-
COMPLICATIONS gist, and ophthalmologist. Factors predis-
In the group presenting without complications, posing children with NF1 towards the develop-
2.4 complications developed for each 100 ment of complications remain to be
person-years. By way of illustration, follow up determined. Children without complications
of 20 children presenting without complica- should be seen every one to two years, unless
tions for five years would lead to the discovery problems arise earlier. Children with complica-
of more than two complications in the total tions at presentation should be examined more
group. This may not seem impressive but the frequently. These children do not have a higher
complications in NF1 are severe and cause risk of subsequent complications than children
both serious morbidity and mortality. We feel presenting without complications. We hope
that follow up of children is indicated on the that our prospective follow up study will be
basis of these data. useful for physicians and clinical geneticists
The incidence rate of subsequent complica- caring for NF1 patients and informing families
tions in children presenting with one or two about the nature and progress of the disease.
complications was 3.0/100 person-years, not
significantly higher than in the group pres- Many thanks to our NF1 patients and their parents for their
enting without complications. cooperation. Special thanks to D F Majoor-Krakauer for initiat-
Because this is the first study on incidence ing the neurofibromatosis project and to Dr H A Moll and Dr C
M van Duijn for their advice with regard to the protocol of the
rates of symptoms and complications in NF1 study and for critical reading of the manuscript.
412 Cnossen, de Goede-Bolder, van den Broek, Waasdorp, Oranje, Stroink, et al
1 Huson SM, Compston DAS, Clark P, Harper PS. A genetic II: guidelines for genetic counselling. J Med Genet 1989;26:
study of von Recklinghausen neurofibromatosis in south 712–21.
east Wales. I. Prevalence, fitness, mutation rate, and eVect 8 Hofman KJ, Harris EL, Bryan RN, Denckla MB. Neurofi-
of parental transmission on severity. J Med Genet bromatosis type 1: the cognitive phenotype. J Pediatr 1994;
Arch Dis Child: first published as 10.1136/adc.78.5.408 on 1 May 1998. Downloaded from http://adc.bmj.com/ on March 17, 2021 by guest. Protected by copyright.
1989;26:704–11. 124(suppl):1–8.
2 National Institutes of Health consensus development 9 Aron AM, Rubenstein AE, Wallace SA, Halperin JC. Learn-
conference statement: neurofibromatosis. Bethesda, MD, ing disabilities in neurofibromatosis. Neurofibromatosis: a
USA, July 13–15, 1987. Neurofibromatosis 1988;1:172–8. handbook for patients, families and health care professionals.
3 Riccardi VM. Neurofibromatosis; phenotype, natural history New York: Thieme, 1990.
and pathogenesis. 2nd ed. Baltimore: The Johns Hopkins 10 Listernick R, Charrow J, Greenwald M, Mets M. Natural
University Press, 1992.
4 Huson SM, Hughes RAC, eds. The neurofibromatoses; a history of optic pathway tumours in children with neurofi-
pathogenetic and clinical overview. London: Chapman and bromatosis type 1: a longitudinal study. J Pediatr 1994;125:
Hall, 1994. 63–6.
5 Cnossen MH, Moons KGM, Garssen MPJ, Pasmans NMT, 11 Cnossen MH, Stam EN, Cooiman CMG, et al. Endocrino-
De Goede-Bolder A, Niermeijer MF. Minor disease features logical disorders and optic pathway glioma in children with
in neurofibromatosis type 1 (NF1) and their possible value in neurofibromatosis type 1. Paediatrics 1997;100:667–70.
diagnosis of NF1 in children younger than 6 years of age and 12 Listernick R, Charrow J, Greenwald M. Emergence of optic
clinically suspected of NF1. J Med Genet. [In press.] pathway gliomas in children with neurofibromatosis type 1
6 Obringer AC, Meadows AT, Zackai EH. The diagnosis of after normal neuroimaging results. J Pediatr 1992;121:584–
neurofibromatosis-1 in the child under the age of 6 years. 7.
Am J Dis Child 1989;143:717–19. 13 Cohen ME, DuVner PK. Visual evoked responses in
7 Huson SM, Compston DAS, Harper PS. A genetic study of children with and without neurofibromatosis. Child’s Brain
von Recklinghausen neurofibromatosis in south east Wales. 1988;10:99–111.